The highs and lows of venetoclax with hypomethylating agents for refractory AML

被引：0
|
作者：
Brunner, Andrew M. [1 ]
机构：
[1] Massachusetts Gen Hosp, Zero Emerson Pl,Suite 118, Boston, MA 02114 USA
来源：
LEUKEMIA RESEARCH | 2020年 / 91卷
关键词：
Acute myeloid leukemia; Venetoclax; Azacitidine; Decitabine;
D O I：
10.1016/j.leukres.2020.106320
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Venetoclax in patients with acute myeloid leukemia refractory to hypomethylating agents—a multicenter historical prospective study
    Ron Ram
    Odelia Amit
    Tsila Zuckerman
    Ronit Gurion
    Pia Raanani
    Yael Bar-On
    Irit Avivi
    Ofir Wolach
    Annals of Hematology, 2019, 98 : 1927 - 1932
  • [42] Venetoclax combination therapy with hypomethylating agents in young adults with relapsed/refractory acute myeloid leukaemia
    Baez-Gutierrez, Nerea
    Rodriguez-Ramallo, Hector
    Antonia-Perez Moreno, Maria
    Arboli, Eduardo-Rodriguez
    Abdel-Kader Martin, Laila
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2021, 12
  • [43] Association of leukemia genetics with response to venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia
    Aldoss, Ibrahim
    Yang, Dongyun
    Pillai, Raju
    Sanchez, James F.
    Mei, Matthew
    Aribi, Ahmed
    Ali, Haris
    Sandhu, Karamjeet
    Al Malki, Monzr M.
    Salhotra, Amandeep
    Khaled, Samer
    Sun, Weili
    O'Donnell, Margaret
    Snyder, David
    Nakamura, Ryotaro
    Stein, Anthony S.
    Forman, Stephen J.
    Marcucci, Guido
    Pullarkat, Vinod
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (10) : E253 - E255
  • [44] Venetoclax in combination with hypomethylating agents or low dose cytarabine for relapsed and refractory acute myeloid leukemia
    Graveno, Molly E.
    Carulli, Alison
    Freyer, Craig W.
    Mangan, Brendan L.
    Nietupski, Robert
    Loren, Alison W.
    Frey, Noelle, V
    Porter, David L.
    Gill, Saar, I
    Hexner, Elizabeth O.
    Luger, Selina M.
    Martin, Mary Ellen
    McCurdy, Shannon R.
    Perl, Alexander E.
    Babushok, Daria, V
    Pratz, Keith W.
    LEUKEMIA & LYMPHOMA, 2022, 63 (07) : 1645 - 1650
  • [45] Clinical experience with venetoclax and hypomethylating agents (HMA) in patients with newly diagnosed and relapsed or refractory KMT2A-Rearranged acute myeloid leukemia (AML)
    Ball, Brian J.
    Arslan, Shukaib
    Koller, Paul
    Ngo, Dat
    Afkhami, Michelle
    Salhotra, Amandeep
    Al-Malki, Monzr
    Aribi, Ahmed
    Ali, Haris
    Sandhu, Karamjeet
    Otoukesh, Salman
    Amanam, Idoroenyi
    Pourhassan, Hoda
    Artz, Andrew
    Curtin, Peter
    Stein, Anthony
    Nakamura, Ryotaro
    Marcucci, Guido
    Smith, Eileen
    Pullarkat, Vinod
    Aldoss, Ibrahim
    LEUKEMIA & LYMPHOMA, 2022, 63 (13) : 3232 - 3236
  • [46] Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort
    Stahl, Maximilian
    DeVeaux, Michelle
    Montesinos, Pau
    Itzykson, Raphael
    Ritchie, Ellen K.
    Sekeres, Mikkael A.
    Barnard, John D.
    Podoltsev, Nikolai A.
    Brunner, Andrew M.
    Komrokji, Rami S.
    Bhatt, Vijaya R.
    Al-Kali, Aref
    Cluzeau, Thomas
    Santini, Valeria
    Fathi, Amir T.
    Roboz, Gail J.
    Fenaux, Pierre
    Litzow, Mark R.
    Perreault, Sarah
    Kim, Tae Kon
    Prebet, Thomas
    Vey, Norbert
    Verma, Vivek
    Germing, Ulrich
    Miguel Bergua, Juan
    Serrano, Josefina
    Gore, Steven D.
    Zeidan, Amer M.
    BLOOD ADVANCES, 2018, 2 (08) : 923 - 932
  • [47] Packaging highs and lows
    Holland, Caryl
    Ink Maker, 2005, 83 (05): : 16 - 21
  • [48] THE HIGHS AND LOWS OF LIME
    RITTENHOUSE, RC
    POWER ENGINEERING, 1992, 96 (03) : 16 - 16
  • [49] HIGHS AND LOWS IN ANTIMONY
    STRINGER, J
    CHEMICAL WEEK, 1995, 156 (14) : 14 - 14
  • [50] THE HIGHS AND LOWS OF LSD
    Thomson, Helen
    NEW SCIENTIST, 2010, 207 (2776) : 9 - 9
12345